CUE
Cue Biopharma·NASDAQ
--
--(--)
--
--(--)
CUE Filings
Filing Date
Form Description
Form Type
2026-03-27
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2026-03-27 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2026-03-27
Form 8-K - Current report
Key Events
2026-03-27 · Key Events
Form 8-K - Current report
2026-03-16
Form S-3 - Registration statement under Securities Act of 1933
2026-03-16 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-03-16
Form ARS - Annual Report to Security Holders
2026-03-16 ·
Form ARS - Annual Report to Security Holders
2026-03-16
Form DEF 14A - Other definitive proxy statements
Key Events
2026-03-16 · Key Events
Form DEF 14A - Other definitive proxy statements
2026-03-16
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-16 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-16
Form 8-K - Current report
Key Events
2026-03-16 · Key Events
Form 8-K - Current report
2026-03-06
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-03-06 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-02-18
Form 8-K - Current report
Key Events
2026-02-18 · Key Events
Form 8-K - Current report
2026-02-12
Form 8-K - Current report
Key Events
2026-02-12 · Key Events
Form 8-K - Current report
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
